eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Rosemont Pharmaceuticals Limited
Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
Telephone: +44 (0)113 244 1400
Fax: +44 (0)113 246 0738
WWW: http://www.rosemontpharma.com
Customer Care direct line: +44 (0)800 919 312
Out of Hours Telephone: +44 (0)7836 557 879
Out of Hours contact: pharmacovigilance@rosemontpharma.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 02/02/2012
PIL Ranitidine 150mg/10ml Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to drug interactions
Updated on 14/03/2011 and displayed until 02/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 24/03/2010 and displayed until 14/03/2011
Reasons for adding or updating:
  • Change to dosage and administration
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 25/10/2007 and displayed until 24/03/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 28/09/2007 and displayed until 25/10/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to date of revision
  • Change to dosage and administration
  • Change of special precautions for disposal
Updated on 21/09/2005 and displayed until 28/09/2007
Reasons for adding or updating:
  • Change to packaging
  • Change to date of revision
Updated on 25/09/2002 and displayed until 21/09/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  ranitidine hydrochloride